Michael W. Dunne - 25 Sep 2022 Form 4 Insider Report for Iterum Therapeutics plc (ITRM)

Role
Director
Signature
/s/ Michael W. Dunne
Issuer symbol
ITRM
Transactions as of
25 Sep 2022
Transactions value $
$0
Form type
4
Date filed
27 Sep 2022, 21:00
Previous filing
27 Feb 2023
Next filing
28 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITRM Restricted Share Units Award $0 +1.78K $0.00 1.78K 25 Sep 2022 Ordinary Shares 1.78K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted share unit ("RSU") represents the contingent right to receive one ordinary share upon vesting of the RSU.
F2 Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's 2018 Amended and Restated 2018 Equity Incentive Plan, as amended, the RSUs shall vest in full on July 1, 2023.